Blood thinners reduce deaths among coronavirus patients, stu
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
Blood thinners appear to reduce the risk of death by up to 50% among seriously ill, hospitalized coronavirus patients. And patients are given anticoagulants also were 30% less likely to need a ventilator to help them breathe, according to the study published in the Journal of the American College of Cardiology.

Key Insights:

• Their study of more than 4,300 patients, also those who died, often had evidence of blood clots throughout their bodies, even though many of them had no symptoms of the problem.

• For the primary outcome of in-hospital mortality, compared with no anticoagulation, therapeutic and prophylactic anticoagulation were associated with lower risk. The risk was also lower for the secondary endpoint of intubation.

• 60% of patients who were not given anticoagulants were discharged alive, 26% of them died in the hospital and 13% were still in the hospital.

• When patients got the drug prophylactically to prevent blood clots, 75% were released alive, 22% died in the hospital and 3% were still hospitalized during the study period.

• Reduction in the risk of death was similar in patients who got anticoagulants either to prevent clots or after they began showing evidence of clotting.

"This work from the Mount Sinai COVID Informatics Center provides additional insight on the role of anticoagulation in the management of patients admitted to the hospital with COVID-19," says senior corresponding author Valentin Fuster, MD, PhD, MACC.

j●●●●●h k●●●r and 6 others like this3 shares